OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Allergy and Clinical Immunology-In Practice is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Table of Contents	180
Sticking With It: The Continued Benefits of 2 Years of Peanut Epicutaneous Immunotherapy in Young Children	144
Indoor and Outdoor Fungal Allergens and Impacts on Respiratory Allergic Disease	134
Carboplatin risk stratification after a hypersensitivity reaction: Progress in our understanding of skin testing	117
Reply to “Correlation, causation, and confounding: How worried should we be about dementia risk and second-generation antihistamines?”	110
Managing CPAP Rhinitis	102
Adherence Challenges and Strategies in Specific Groups With Asthma: Adolescents, Pregnancy, and Older Adults	94
Could Corticosteroid/Antihistamine Combination Nasal Sprays Be Used as Anti-Inflammatory Reliever Therapy for Allergic Rhinitis?	91
Table of Contents	89
Respiratory Diseases Associated With Organic Dust Exposure	86
Once- or Twice-Daily Inhaler Therapy for Optimal Adherence: “No-Brainer” or Shared Decision?	84
Endoscopic Evaluation of Patients With Food Allergy for Eosinophilic Esophagitis Before Oral Immunotherapy	82
Weight Loss Interventions for Adults With Obesity-Related Asthma	78
Comparative diagnostic performance of mx4-IgE versus species-specific IgE for identifying allergic bronchopulmonary aspergillosis	78
Effects of Sex and Gender in Immediate β-Lactam Antibiotic Allergy: A Systematic Review and Meta-Analysis	77
Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders	74
The Role of Patient Satisfaction Scores in Clinical Care and Physician Wellness	74
Cumulative Dose Effects of H1 Antihistamine Use on the Risk of Dementia in Patients With Allergic Rhinitis	72
Understanding Health Equity in Patient-Reported Outcomes	71
Risk Factors of Hypersensitivity Reactions to Carboplatin: A Systematic Review and Meta-Analysis	70
Evolving Food Allergy Clinical Trials to Become More Patient-Centered	68
Combination of Allergen-Specific Immunotherapy With Biologics in Severe Asthma: Counterintuitive or Rational?	67
Artificial Intelligence and Machine Learning for Inborn Errors of Immunity: Current State and Future Promise	67
Chronic norovirus infection in immunodeficiency: A UK national case series	64
A Media Advocacy Toolkit for the Allergist-Immunologist	63

Reply to “Correspondence on ‘Neuropsychiatric events related to montelukast and pranlukast in adults with asthma and rhinitis: a 10-year nationwide population-based study’”	62
Impact of Ongoing Treatment With Inhaled Corticosteroids During Specific Inhalation Challenges for Diagnosing Occupational Asthma	61
Measuring Cough Severity: Time to Replace VAS With Patient Global Impression Scale?	61
Facilitated Subcutaneous Immunoglobulin 10% Safety Among Pediatric Patients With Primary Immunodeficiency Diseases	61
Allergic Rash Mimickers	59
Table of Contents	58
Effects of Pregnancy-Onset Asthma on Perinatal Outcomes: A Retrospective Cohort Study	56
Smoking in severe asthma: Unraveling the overlap with COPD	56
Prevention of IgE-Mediated Food Allergy: Emerging Strategies Through Maternal and Neonatal Interventions	55
Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis	55
Disparities in Genetic Testing for Inborn Errors of Immunity	55
Hypereosinophilia following aspirin desensitization for aspirin-exacerbated respiratory disease	54
Epinephrine Nasal Spray Improves Allergic Symptoms in Patients Undergoing Oral Food Challenge, Phase 3 Trial	54
CME exam: Practical Implementation of Genetics: New Concepts in Immunogenomics to Predict, Prevent, and Diagnose Drug Hypersensitivity	53
Practice Notes from the AAAI	52
The impact of COVID-19 on a national sample of US adults with food allergy	52
Usability of Graphical User Interfaces With Semiautomatic Delabeling Feature to Improve Drug Allergy Documentation	51
Two-step nonsteroidal anti-inflammatory drug challenges during pregnancy: A case series	51
Another Therapy for Chronic Rhinosinusitis With Nasal Polyps	50
Pharmaceutical industry-sponsored meals and prescriptions of biologics for asthma	50
Artificial Intelligence Chatbots in Allergy and Immunology Practice: Where Have We Been and Where Are We Going?	49
Feeding difficulties in children with food protein–induced enterocolitis syndrome	49
Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines	48